Colombia’s first Canadian stock listing could lure capital to medical marijuana

0
161

By Matt Lamers With a potential patient count more than double Canada’s, Colombia’s medical marijuana market is quickly gaining recognition as a legitimate force in the global cannabis industry. The total market for patients with qualifying conditions in Colombia exceeds 5.5 million people, according to QuantilesIMS, a U.S.-based market analytics company. The country, which has long been known for its black-market drug industry, has developed a comprehensive framework to boost the industry. In addition, Colombian companies are gaining recognition in other ways. Khiron Life Sciences became the first Colombian medical cannabis company on the TSX Venture Exchange when it started trading Thursday under the symbol KHRN. “It means capital markets are accepting Colombia as a valid market for medical cannabis. Colombia’s first Canadian stock listing could lure capital to medical marijuana

thumbnail courtesy of mjbizdaily.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here